MERCK & CO's gross profit margin for the fourth quarter of its fiscal year 2015 has decreased when compared to the same period a year ago. Sales and net income have dropped, underperforming the average competitor within its industry.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY15||Q4 FY14|
|Net Sales ($mil)||10215.0||10482.0|
|Net Income ($mil)||977.0||7316.0|
|Balance Sheet||Q4 FY15||Q4 FY14|
|Cash & Equiv. ($mil)||0.0||15719.0|
|Total Assets ($mil)||0.0||98335.0|
|Total Debt ($mil)||0.0||21403.0|
|Profitability||Q4 FY15||Q4 FY14|
|Gross Profit Margin||63.71||78.22|
|Return on Assets||0.0||12.12|
|Return on Equity||0.0||24.5|
|Debt||Q4 FY15||Q4 FY14|
|Share Data||Q4 FY15||Q4 FY14|
|Shares outstanding (mil)||2802.24||2838.14|
|Div / share||0.46||0.45|
|Book value / share||0.0||17.14|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1.1233313E7||1.3418641E7|
HOLD. This stock's P/E ratio indicates a premium compared to an average of 27.42 for the Pharmaceuticals industry and a significant premium compared to the S&P 500 average of 21.13. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average.
|MRK 31.15||Peers 27.42||MRK NA||Peers 26.07|
Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.
MRK is trading at a premium to its peers.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|MRK 12.75||Peers 14.46||MRK NM||Peers 0.64|
Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.
MRK is trading at a valuation on par with its peers.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
MRK's negative PEG ratio makes this valuation measure meaningless.
|MRK NA||Peers 7.00||MRK -61.96||Peers 20.80|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
Ratio not available.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, MRK is expected to significantly trail its peers on the basis of its earnings growth rate.
|MRK 3.45||Peers 13.10||MRK -6.49||Peers 11.56|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
MRK is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
MRK significantly trails its peers on the basis of sales growth
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.